By Robb M. Stewart

 

Moderna Inc. will sell an additional 50 million doses of its Covid-19 vaccine and its updated variant booster candidate, if authorized, to Japan's government and Takeda Pharmaceutical Co., doubling the size of its prior supply agreement.

Moderna said it is responsible for the manufacture and supply of its vaccine candidate. Takeda, with the support of the Ministry of Health, Labour and Welfare of Japan and Moderna, is responsible for all import, local regulatory, development and distribution activities in Japan for the additional 50 million doses beginning in 2022, Moderna said.

 

Write to Robb M. Stewart at robb.stewart@wsj.com

 

(END) Dow Jones Newswires

July 20, 2021 07:16 ET (11:16 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Moderna Charts.